Wed, Nov 09
|Virtual/Live
Kicking Cancer's KRAS Expert Series with Dr. Mark Awad
Join us for a conversation about Resistance in KRAS-driven Cancers with Dr. Mark Awad, Clinical Director, Thoracic Oncology Treatment Center at Dana Farber. RSVP for the meeting link.
Time & Location
Nov 09, 2022, 2:00 PM – 3:30 PM EST
Virtual/Live
About the Event
Mark Awad, M.D., Ph.D., is an Assistant Professor of Medicine at Harvard Medical School and Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute. Dr. Awad received his undergraduate degree from Harvard University and his M.D. and Ph.D. degrees from the Johns Hopkins School of Medicine. His translational research focus is on identifying biomarkers of response and resistance to targeted therapies and immunotherapies in lung cancer. He is the principal investigator of several clinical trials for patients with thoracic malignancies and collaborates closely with laboratory-based investigators.
Thank you to our Champion Partner, AMGEN, for helping us kick cancer's KRAS!
This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.
© 2024 KRAS Cancer Connect. All rights reserved. Nonprofit EIN 85-4372947